Will Leo Pharma’s Adtralza® (tralokinumab) get its U.S. Food and Drug Administration (FDA) approval this year? While there’s no confirmation yet, the pharmaceutical company has already received a Positive CHMP Opinion for the treatment.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,